Licensing Opportunities
Cipro Pharmaceuticals also offers out licensing of in house developed products, creating opportunities for global collaboration.
- Proprietary formulations developed by the R&D team can be licensed to international partners based on client requirements.
- This model allows companies to access ready to market products without investing in development infrastructure.
- Out licensing strengthens Cipro’s global footprint while enabling partners to expand their portfolios with quality assured, compliant formulations.
- Flexible collaboration models ensure a win win business situation, fostering long term partnerships across geographies.